CD36 and neoplasm: However, currently, there are no molecules safe for in vivo use that can effectively inhibit CD36 protein activity [12], and understanding the functional mechanism that regulates CD36 expression, which has not yet been fully elucidated, could allow the development of a useful therapeutic strategy for indirectly blocking CD36 activity and FA uptake in tumor cells.